• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核 NPM-ALK 保护 Myc 免于蛋白酶体降解,并有助于 ALK 阳性间变大细胞淋巴瘤中的癌症干细胞样细胞中高表达。

Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma.

机构信息

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada.

Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB T6G 2R3, Canada.

出版信息

Int J Mol Sci. 2023 Sep 20;24(18):14337. doi: 10.3390/ijms241814337.

DOI:10.3390/ijms241814337
PMID:37762644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10531997/
Abstract

In ALK-positive anaplastic large cell lymphoma (ALK+ALCL), a small subset of cancer stem-like (or RR) cells characterized by high Myc expression have been identified. We hypothesize that NPM-ALK contributes to their high Myc expression. While transfection of into HEK293 cells effectively increased Myc by inhibiting its proteosomal degradation (PD-Myc), this effect was dramatically attenuated when the full-length NPM1 (FL-NPM1) was downregulated using shRNA, highlighting the importance of the NPM-ALK:FL-ALK heterodimers in this context. Consistent with this concept, immunoprecipitation experiments showed that the heterodimers are abundant only in RR cells, in which the half-life of Myc is substantially longer than the bulk cells. Fbw7γ, a key player in PD-Myc, is sequestered by the heterodimers in RR cells, and this finding correlates with a Myc phosphorylation pattern indicative of ineffective PD-Myc. Using confocal microscopy and immunofluorescence staining, we found that the fusion signal between ALK and FL-NPM1, characteristic of the heterodimers, correlates with the Myc level in ALK+ALCL cells from cell lines and patient samples. To conclude, our findings have revealed a novel oncogenic function of NPM-ALK in the nucleus. Specifically, the NPM-ALK:FL-NPM1 heterodimers increase cancer stemness by blocking PD-Myc and promoting Myc accumulation in the cancer stem-like cell subset.

摘要

在间变性大细胞淋巴瘤(ALK+ALCL)中,一小部分具有高 Myc 表达特征的癌症干细胞样(或 RR)细胞已被鉴定出来。我们假设 NPM-ALK 有助于它们高 Myc 表达。虽然转染到 HEK293 细胞中可以通过抑制其蛋白酶体降解(PD-Myc)来有效增加 Myc,但当使用 shRNA 下调全长 NPM1(FL-NPM1)时,这种效应显著减弱,这突出了 NPM-ALK:FL-ALK 异二聚体在这种情况下的重要性。与这一概念一致,免疫沉淀实验表明,只有在 RR 细胞中才存在丰富的异二聚体,在 RR 细胞中 Myc 的半衰期明显长于大部分细胞。Fbw7γ 是 PD-Myc 的关键调控因子,在 RR 细胞中被异二聚体隔离,这一发现与 Myc 磷酸化模式相关,表明 PD-Myc 无效。通过共聚焦显微镜和免疫荧光染色,我们发现,ALK 和 FL-NPM1 之间的融合信号,是异二聚体的特征,与来自细胞系和患者样本的 ALK+ALCL 细胞中的 Myc 水平相关。总之,我们的发现揭示了 NPM-ALK 在核内的一种新的致癌功能。具体来说,NPM-ALK:FL-NPM1 异二聚体通过阻断 PD-Myc 并促进 Myc 在癌症干细胞样细胞亚群中的积累,增加了癌症干细胞样性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/c8d54f28bc24/ijms-24-14337-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/59a7908b6960/ijms-24-14337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/39133343c11a/ijms-24-14337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/635338dbcc80/ijms-24-14337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/cfc9e00593af/ijms-24-14337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/ece8e2c05539/ijms-24-14337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/966c4f41aef3/ijms-24-14337-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/c8d54f28bc24/ijms-24-14337-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/59a7908b6960/ijms-24-14337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/39133343c11a/ijms-24-14337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/635338dbcc80/ijms-24-14337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/cfc9e00593af/ijms-24-14337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/ece8e2c05539/ijms-24-14337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/966c4f41aef3/ijms-24-14337-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3437/10531997/c8d54f28bc24/ijms-24-14337-g007.jpg

相似文献

1
Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma.核 NPM-ALK 保护 Myc 免于蛋白酶体降解,并有助于 ALK 阳性间变大细胞淋巴瘤中的癌症干细胞样细胞中高表达。
Int J Mol Sci. 2023 Sep 20;24(18):14337. doi: 10.3390/ijms241814337.
2
The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.热休克蛋白 90 共伴侣蛋白,亲环素 40,促进间变性大细胞淋巴瘤 ALK 阳性细胞的存活,其表达受 NPM-ALK 癌蛋白的调控。
BMC Cancer. 2012 Jun 8;12:229. doi: 10.1186/1471-2407-12-229.
3
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency.NPM-ALK致癌信号的过度激活会促进细胞凋亡和药物依赖性。
Oncogene. 2016 Jul 21;35(29):3854-3865. doi: 10.1038/onc.2015.456. Epub 2015 Dec 14.
4
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.Grb2 衔接蛋白在核磷蛋白-间变性淋巴瘤激酶(NPM-ALK)介导的信号转导和间变大细胞淋巴瘤生长中的作用。
J Biol Chem. 2010 Aug 20;285(34):26441-50. doi: 10.1074/jbc.M110.116327. Epub 2010 Jun 16.
5
Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.水飞蓟宾可抑制核仁磷酸蛋白-间变性淋巴瘤激酶(NPM-ALK),有效诱导细胞凋亡,并增强ALK阳性间变性大细胞淋巴瘤的化疗敏感性。
Leuk Lymphoma. 2016 May;57(5):1154-62. doi: 10.3109/10428194.2015.1068306. Epub 2015 Jul 1.
6
STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.STAT1 被致癌酪氨酸激酶 NPM-ALK 在 ALK 阳性间变大细胞淋巴瘤中磷酸化和下调。
Blood. 2015 Jul 16;126(3):336-45. doi: 10.1182/blood-2014-10-603738. Epub 2015 Apr 28.
7
EBP2, a novel NPM-ALK-interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53.EBP2,核仁中一种新型的 NPM-ALK 相互作用蛋白,通过调节肿瘤抑制因子 p53 促进 ALCL 细胞的增殖。
Mol Oncol. 2021 Jan;15(1):167-194. doi: 10.1002/1878-0261.12822. Epub 2020 Nov 19.
8
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.PF-2341066(一种间变性淋巴瘤激酶和c-Met的新型抑制剂)在间变性大细胞淋巴瘤实验模型中的减瘤抗肿瘤活性。
Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3314-22. doi: 10.1158/1535-7163.MCT-07-0365.
9
Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.间变性大细胞淋巴瘤中间变性淋巴瘤激酶/蛋白激酶B/雷帕霉素哺乳动物靶标信号通路激活的预后意义及治疗潜力
BMC Cancer. 2013 Oct 10;13:471. doi: 10.1186/1471-2407-13-471.
10
Preclinical Evaluation of Gilteritinib on NPM1-ALK-Driven Anaplastic Large Cell Lymphoma Cells.NPM1-ALK 驱动的间变大细胞淋巴瘤细胞的吉瑞替尼的临床前评估。
Mol Cancer Res. 2021 May;19(5):913-920. doi: 10.1158/1541-7786.MCR-20-0738. Epub 2021 Jan 29.

本文引用的文献

1
STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.STAT3 将激活的酪氨酸激酶信号与间变大细胞淋巴瘤的致癌核心转录调控回路偶联。
Cell Rep Med. 2024 Mar 19;5(3):101472. doi: 10.1016/j.xcrm.2024.101472.
2
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版:淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
3
Cancer Stem Cells-Key Players in Tumor Relapse.
癌症干细胞——肿瘤复发的关键因素
Cancers (Basel). 2021 Jan 20;13(3):376. doi: 10.3390/cancers13030376.
4
NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target.NPM-ALK:淋巴瘤发病机制的驱动因素及治疗靶点
Cancers (Basel). 2021 Jan 5;13(1):144. doi: 10.3390/cancers13010144.
5
Crizotinib Resistance Mediated by Autophagy Is Higher in the Stem-Like Cell Subset in ALK-Positive Anaplastic Large Cell Lymphoma, and This Effect Is MYC-Dependent.在ALK阳性间变性大细胞淋巴瘤的干细胞样细胞亚群中,自噬介导的克唑替尼耐药性更高,且这种效应依赖于MYC。
Cancers (Basel). 2021 Jan 7;13(2):181. doi: 10.3390/cancers13020181.
6
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy.肺癌靶向治疗中肿瘤异质性和耐药机制的新见解。
J Hematol Oncol. 2019 Dec 9;12(1):134. doi: 10.1186/s13045-019-0818-2.
7
NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma.NPM-ALK是ALK阳性间变性大细胞淋巴瘤中癌蛋白FOXM1的关键调节因子。
Cancers (Basel). 2019 Aug 6;11(8):1119. doi: 10.3390/cancers11081119.
8
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.致癌激活 STAT3 通路驱动自然杀伤/T 细胞淋巴瘤中 PD-L1 的表达。
Blood. 2018 Sep 13;132(11):1146-1158. doi: 10.1182/blood-2018-01-829424. Epub 2018 Jul 27.
9
Emerging roles of Myc in stem cell biology and novel tumor therapies.Myc 在干细胞生物学和新型肿瘤治疗中的新兴作用。
J Exp Clin Cancer Res. 2018 Jul 27;37(1):173. doi: 10.1186/s13046-018-0835-y.
10
Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.氧化应激通过激活 ALK 阳性间变大细胞淋巴瘤中的 Wnt/β-catenin/MYC/Sox2 轴增强肿瘤发生和干细胞样特征。
BMC Cancer. 2018 Apr 2;18(1):361. doi: 10.1186/s12885-018-4300-2.